Abiopharma

La Francia espande laccesso nazionale allAAC per botensilimab + balstilimab di Agenus per il carcinoma ovarico e i sarcomi dei tessuti molli

Sarepta Reports Preliminary* Fourth Quarter and Full-Year 2025 Net Product Revenues

Smith+Nephew PLC Notification

Investis Notification - Smith+Nephew PLC

Biohaven Highlights Portfolio Progress, Positive Early Patient Data from Priority Degrader Programs and Anticipated Milestones at the 44th Annual J.P. Morgan Healthcare Conference

Biogen Receives European Commission Approval for High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy

NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery In the Age of AI

BridgeBio Announces Commercial Progress, Program Updates, and 2026 Milestones at the 44th Annual J.P. Morgan Healthcare Conference

AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2025, Provides Financial Outlook for 2026

Eastman Chemical Company - Eastman Schedules Fourth-Quarter and Full-Year 2025 Financial Results News Release and SEC Form 8-K Filing, Teleconference and Webcast, and Release of Additional Information